Ads
related to: biotech pharmaceuticals
Search results
Cathie Wood's ARK buys AMD, sells Moderna in latest stock trades By Investing.com
Investing.com· 1 day agoCathie Wood's ARK buys AMD, sells Moderna in latest stock trades
Fans can finally get a chance to listen to the Wu-Tang Clan’s one copy album… but there’s a catch |...
CNN.com· 1 day ago“Once Upon a Time in Shaolin” is as mysterious as its title. Recorded by legendary hip-hop group...
Sanofi’s CEO thinks OpenAI offers 'insane' potential for the pharmaceutical industry
Fortune· 18 hours agoIf generative AI is going to be more than hype and hallucinations, the trillion-dollar pharma industry is where the magic may happen. Last week, Hudson proudly announced his company’s new partnership ...
AstraZeneca, Merck, GSK Struck Record $44.1B Licensing Deals With Chinese Drugmakers In 2023: Report...
Benzinga· 3 days agoWestern pharmaceutical companies and investors are driving a record number of licensing deals with...
3 High-Flying Stocks That Could Soar Even More
Motley Fool via Yahoo Finance· 5 days agoMultiple catalysts on the horizon Prosper Junior Bakiny (Vertex Pharmaceuticals): It's hard to argue against results like those produced by Vertex ...
Amphastar Pharmaceuticals (NASDAQ:AMPH) Shares Up 4.6%
ETF DAILY NEWS· 6 days agoAmphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Get Free Report) rose 4.6% during mid-day trading on Wednesday . Approximately 54,293 shares traded hands during trading, a ...
3 Reasons to Buy CRISPR Therapeutics Stock Like There's No Tomorrow | The Motley Fool
The Motley Fool· 4 days agos first commercialized product, a gene therapy called Casgevy, which treats or functionally cures both sickle cell disease (SCD) and beta thalassemia, is in the midst of its global rollout.
CAI And Fedegari Group Announce New Partnership To Deliver Turnkey Sterilization Solutions To Drug...
BioresearchOnline· 6 days agoCAI, a global company that provides technical, operational consulting, and project management...
Surprise: Eli Lilly Is Racing Toward Yet Another Blockbuster
Motley Fool via Yahoo Finance· 7 days agoEli Lilly's top line should rise much faster than the average for biotech giants in the next five...
We Still Aren’t Testing Enough Farmers for Bird Flu
Bloomberg· 6 days agoLisa Jarvis is a Bloomberg Opinion columnist covering biotech, health care and the pharmaceutical industry. Previously, she was executive editor of...
